site without changing your settings, you are agreeing to accept all cookies on the site.
Healthcare providers and first responders, if you are inquiring about Battelle CCDS Critical Care Decontamination System™,
please review our FAQ for up-to-date information, site locations, and to enroll.
Personal Protective Equipment (PPE) decontamination for reuse
As new drug formulations demand new answers, Battelle is developing novel solutions to these challenges.
Modeling the movement of PFAS plumes in groundwater
When you are looking to select or develop the optimal delivery mechanism for a new drug or therapy and accelerate their path through the regulatory process, think Battelle.
Battelle’s Biomedical Research Center (BRC) contains the largest privately owned Biosafety Level 3 (BSL-3) facility in the United States.
Battelle works daily at the intersection of science and technology and is pioneering ways to help people overcome devastating neurological damage and disorders.
From the field to the lab, Battelle is leading the way in development of new solutions for emerging environmental problems—like per- and polyfluoroalkyl substances (PFAS).
For a person with a nervous system injury, everyday tasks can be overwhelming – if not impossible. Battelle’s technology aims to help patients overcome these hurdles.
Battelle offers valuable analysis and assessment for vaccines, prophylactic compounds and therapeutics for a wide array of infectious diseases, medical countermeasures and biological threats.
VIDEO: Battelle Critical Care Decontamination System
Thanks to COVID-19, these are heady days for telemedicine, where the future again looks bright and change is on the horizon. But will that last?
This month, we feature NEON’s involvement in supporting researchers and agencies in the development of new biodiversity tools and resources.
As libraries and museums around the country begin to reopen to the public, the need for safe handling of core library, archival and museum materials is increasingly urgent.